Long-Term Treatment Outcomes of Primary Alveolar Bone Grafts for Alveolar Clefts: A Qualitative Systematic Review.


Journal

The Cleft palate-craniofacial journal : official publication of the American Cleft Palate-Craniofacial Association
ISSN: 1545-1569
Titre abrégé: Cleft Palate Craniofac J
Pays: United States
ID NLM: 9102566

Informations de publication

Date de publication:
01 2022
Historique:
pubmed: 27 2 2021
medline: 3 2 2022
entrez: 26 2 2021
Statut: ppublish

Résumé

Alveolar bone grafting is utilized to manage alveolar clefts in patients with cleft lip and palate. However, the timing of bone grafting is variable with conflicting evidence supporting the use of primary alveolar bone grafting (PABG) in clinical practice. To provide a qualitative systematic review analysis of long-term outcomes after PABG. A qualitative systematic review was performed following the Cochrane Handbook and reported using Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Summative findings were evaluated using Confidence in the Evidence from Reviews of Qualitative research to assess the quality of evidence supporting the findings. After removing duplication, 2182 publications were identified, and 2131 were excluded after screening through titles and abstracts. Inclusion criteria for this study included patients who underwent PABG at 24 months of age or younger and a minimum of 5 year follow-up. Thirty-two publications met the inclusion criteria and were included for qualitative analysis. Primary outcome measures included cephalometric analysis, bone graft survival, occlusal analysis, hypomineralization, tooth eruption, radiograph analysis, and arch relationships. Four assessment themes were characterized from the systematic review: (1) bone graft survival, (2) craniofacial skeletal relationships, (3) occlusion and arch forms, and (4) recommendations for utilizing PABG in practice. The reported systematic review provides evidence that performing PABG leads to poor long-term outcomes related to bone graft survival and maxillary growth restriction despite some reported positive outcomes.

Sections du résumé

BACKGROUND
Alveolar bone grafting is utilized to manage alveolar clefts in patients with cleft lip and palate. However, the timing of bone grafting is variable with conflicting evidence supporting the use of primary alveolar bone grafting (PABG) in clinical practice.
PRIMARY AIM
To provide a qualitative systematic review analysis of long-term outcomes after PABG.
MATERIALS AND METHODS
A qualitative systematic review was performed following the Cochrane Handbook and reported using Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. Summative findings were evaluated using Confidence in the Evidence from Reviews of Qualitative research to assess the quality of evidence supporting the findings.
RESULTS
After removing duplication, 2182 publications were identified, and 2131 were excluded after screening through titles and abstracts. Inclusion criteria for this study included patients who underwent PABG at 24 months of age or younger and a minimum of 5 year follow-up. Thirty-two publications met the inclusion criteria and were included for qualitative analysis. Primary outcome measures included cephalometric analysis, bone graft survival, occlusal analysis, hypomineralization, tooth eruption, radiograph analysis, and arch relationships. Four assessment themes were characterized from the systematic review: (1) bone graft survival, (2) craniofacial skeletal relationships, (3) occlusion and arch forms, and (4) recommendations for utilizing PABG in practice.
CONCLUSION
The reported systematic review provides evidence that performing PABG leads to poor long-term outcomes related to bone graft survival and maxillary growth restriction despite some reported positive outcomes.

Identifiants

pubmed: 33631994
doi: 10.1177/1055665621995047
doi:

Types de publication

Journal Article Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

86-97

Auteurs

M Kristine Carbullido (MK)

Division of Plastic Surgery, Department of Surgery, University of California, San Diego, La Jolla, CA, USA.

Riley A Dean (RA)

Division of Plastic Surgery, Department of Surgery, University of California, San Diego, La Jolla, CA, USA.

George N Kamel (GN)

Division of Plastic Surgery, Department of Surgery, University of California, San Diego, La Jolla, CA, USA.
Fresh Start Center for Craniofacial Anomalies, 14444Rady Children's Hospital, San Diego, CA, USA.

Greta L Davis (GL)

School of Medicine, University of California, San Diego, La Jolla, CA, USA.

Michael Hornacek (M)

Division of Plastic Surgery, Department of Surgery, University of California, San Diego, La Jolla, CA, USA.

Rachel M Segal (RM)

Division of Plastic Surgery, Department of Surgery, University of California, San Diego, La Jolla, CA, USA.

Emily Ewing (E)

Fresh Start Center for Craniofacial Anomalies, 14444Rady Children's Hospital, San Diego, CA, USA.

Samuel H Lance (SH)

Division of Plastic Surgery, Department of Surgery, University of California, San Diego, La Jolla, CA, USA.
Fresh Start Center for Craniofacial Anomalies, 14444Rady Children's Hospital, San Diego, CA, USA.

Amanda A Gosman (AA)

Division of Plastic Surgery, Department of Surgery, University of California, San Diego, La Jolla, CA, USA.
Fresh Start Center for Craniofacial Anomalies, 14444Rady Children's Hospital, San Diego, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH